
Alpine Immune Sciences developed innovative protein-based immunotherapies for autoimmune and inflammatory diseases prior to its acquisition by Vertex Pharmaceuticals.
Alpine Immune Sciences, Inc., based in Seattle, is a clinical-stage biopharmaceutical company specializing in innovative, protein-based immunotherapies for autoimmune and inflammatory diseases. The company's core mission is to harness the power of the immune system to develop transformative treatments. Alpine has advanced multiple product candidates into clinical trials and formed collaborations with leading partners, focusing on both autoimmune conditions and cancer.
Notable figures affiliated with Alpine include its experienced management team and scientific advisors, who have significantly contributed to its research and development capabilities. The company has achieved key milestones, including advancing its product candidates into clinical trials and forming strategic partnerships. The acquisition by Vertex Pharmaceuticals underscores Alpine's impact and potential in the biopharmaceutical industry, highlighting its contributions to advancing immunotherapy treatments.
Companies similar to Alpine Immune Sciences include Inimmune, Immunome, Cleveland BioLabs and Apellis Pharmaceuticals.
Alpine Immune Sciences was founded in 2015.
Alpine Immune Sciences' headquarters is located in Seattle, WA, US.
As of May 20, 2024, Alpine Immune Sciences has disclosed funding of $476.3M (USD). Undisclosed round amounts are excluded.

Inimmune
inimmune.com

Immunome

Cleveland BioLabs
Apellis Pharmaceuticals
apellis.com

Abacus Bioscience

Equillium
equilliumbio.com

AIM Immunotech
aimimmuno.com

Osprey Pharmaceuticals USA
ospreypharma.com

Asylia Therapeutics
asyliatx.com

IpiNovyx Bio

Inmagene Biopharmaceuticals
inmagenebio.com
Therabiol

ImmuneID

AltruBio

Q32 Bio
q32bio.com